PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy

PURPOSE: This study aimed to determine the correlation between protein induced by vitamin K absence or antagonist-II (PIVKA-II) and stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Sixty-one patients received SBRT between 2015 and 2020 wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ick Joon, Jeong, Jae-Uk, Nam, Taek-Keun, Joo, Young-Eun, Cho, Sung-Bum, Kim, Yong-Hyub, Song, Ju-Young, Yoon, Mee Sun, Ahn, Sung-Ja, Chung, Woong-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984128/
https://www.ncbi.nlm.nih.gov/pubmed/35368197
http://dx.doi.org/10.3857/roj.2021.00934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984128/
https://www.ncbi.nlm.nih.gov/pubmed/35368197
http://dx.doi.org/10.3857/roj.2021.00934

Ejemplares similares